Dosis letal 50 de lorazepam en ratón (Mus musculus) Albino, cepa suizo-icr
Keywords:
DL50 lorazepam, dosis letal, ratones, mortalidad, escopolamina, fármacos, intoxicaciones (es)Downloads
Objetivo: Como un primer paso para estudiar la toxicidad conjunta de mezclas de escopolamina y benzodiacepinas ("nueva burundanga") se determinó la dosis letal 50 (DL50) del lorazepam en ratones (Mus musculus) albinos, cepa suizo ICR. Método: Se utilizaron 60 ratones machos adultos, asignados aleatoriamente a cinco grupos experimentales y uno de control. La dosis de lorazepam administrada por vía intraperitoneal a cada grupo fue: 10mg kg' al grupo 1, 20 mg kg' al grupo II, 40 mg kg' al grupo III, 80 mg kg' al grupo IV, y 160 mg kg' al grupo V. Al grupo de control se le administró solamente la solución vehículo. Se registró la mortalidad durante 15 días después de la administración y se realizó necropsia de los animales muertos durante el ensayo y de los supervivientes al final del mismo. Los datos fueron procesados mediante análisis de probit y estimación de la función de supervivencia. Resultados: La DL50 estimada fue 90.71 mg kg', con intervalo de confianza del 95% entre 65,02 y 150,13 mg kg'. La mortalidad se produjo durante los primeros seis días después de la administración de dosis superiores a los 80 mg kg', siendo mayor en las primeras 48 horas. Conclusiones: La DL50 de lorazepam estimada en nuestro estudio es aproximadamente el doble de la reportada, lo cual sugiere una mayor resistencia de la cepa utilizada en este experimento. El período crítico para la intoxicaciones por lorazepam abarca las primeras 48 horas.
Objective: The lethal dose 50 (LD50) of lorazepam in albino mice (Musmusculus), swiss ICR strain, was determined as a first step in the study of the conjoint toxicity of admixtures of scopolamine and benzodiazepines ("new burundanga"). Method: Sixty adult male mice were randomly assigned to five experimental groups and to a control one. The dose of lorazepam administered intraperitoneally to each group was: group 1,10 mg kg_1; group 11,20 mg kgI; group 111,40mg kgL; group IV,80mgkg'; group V,160mg kg-l.The control group received only the vehicle solution. Mortality was recorded during 15 days after injection. Necropsies were performed to all the mice dead during the assay and to the survivors. Data were processed using probit analysis and survival analysis. Results: Estimated LD50 were 90.71 mg kg- 1, with 95% confidence range of 65,02to 150,13mg kg- 1.Deaths occurred within the first six days after injection of doses higher than 80 mg kg:', mostly during the first 48 hours. Conclusions: The estimated LD50 of lorazepam in this experiment almost doubles the reported one, this finding suggests a higher resistance of the mice strain used in this experiment The critic period for lorazepam poisoning spans the first 48 hours.
How to Cite
APA
ACM
ACS
ABNT
Chicago
Harvard
IEEE
MLA
Turabian
Vancouver
Download Citation
Article abstract page views
Downloads
License
Copyright
Authors must agree to transfer to the Revista de la Facultad de Medicina the copyright of the articles published in the Journal. The publisher has the right to use, reproduce, transmit, distribute and publish the articles in any form. Authors will not be able to permit or authorize the use of their published paper without the written consent of the Journal.
The letter of copyright transfer and the letter of authorship responsibility must be submitted along with the original paper through the Journal OJS platform. These files are available in https://goo.gl/EfWPdX y https://goo.gl/6zztk4 and must be uploaded in step 4 (supplementary files).
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).